RemissionIt was a flawless summer daywhen shivering, in a flimsy paper gown,I tried to focus as a somber physician,pointing at a white spot on a gray ...
Dr Linhares provides clinical insights on factors that guide treatment decisions for patients with chronic lymphocytic leukemia, such as comorbidities and ...
Ojemda may provide a safer treatment option for pediatric patients with low-grade glioma. The recent accelerated Food and Drug Administration (FDA) approval ...
A new delivery system of gemcitabine called TAR-200 resulted in promising responses in patients with high-risk non–muscle-invasive bladder cancer (NMIBC) ...
There have been many stories in the news in the last few years about younger celebrities with cancer, some of whom have died. Recent stories have ...
Josie Montegaard, MSN, AGPCNP-BC, offers expert perspectives on treatment considerations in CLL, focusing on BTK inhibitors and venetoclax-based therapy.
A Biologics License Application for subcutaneous Opdivo was accepted by the FDA for patients with solid tumors. The Food and Drug Administration (FDA) ...
Sheer passion and ambition So, why dedicate a career to pancreatic cancer research? “I want to make a diagnosis of pancreatic cancer less scary than it ...
When Janet discovered she had the BRCA mutation, she did not know anyone else going through a similar experience.Breast and ovarian cancers have a long ...
One oncology nurse explained how her personal experience with cancer in her family has shaped her to be a source of support for patients with cancer.Jessica ...
A PET scan may help doctors determine whether certain patients with HER2-positive early breast cancer require chemotherapy in addition to other ...
- « Previous Page
- 1
- …
- 28
- 29
- 30
- 31
- 32
- …
- 167
- Next Page »